ADMA Biologics, Inc.
ADMA
$8.41
$0.536.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 45.33M | 49.38M | 36.43M | 34.22M | 26.90M |
| Total Depreciation and Amortization | 1.84M | 2.05M | 2.02M | 2.06M | 1.97M |
| Total Amortization of Deferred Charges | 191.00K | 197.00K | 170.00K | 160.00K | 190.00K |
| Total Other Non-Cash Items | 1.65M | 6.54M | 11.99M | 7.71M | 8.01M |
| Change in Net Operating Assets | 9.24M | -22.52M | -37.32M | -23.00M | -56.75M |
| Cash from Operations | 58.25M | 35.64M | 13.29M | 21.14M | -19.68M |
| Capital Expenditure | -2.54M | -1.08M | -14.37M | -2.42M | -4.70M |
| Sale of Property, Plant, and Equipment | 5.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.00K | 808.00K | 0.00 | -105.00K | -19.00K |
| Cash from Investing | 2.40M | -276.00K | -14.37M | -2.53M | -4.72M |
| Total Debt Issued | 125.00M | 0.00 | 75.00M | 30.00M | -- |
| Total Debt Repaid | -469.00K | -469.00K | -75.47M | -30.00M | -- |
| Issuance of Common Stock | 588.00K | 430.00K | 389.00K | 2.06M | 101.00K |
| Repurchase of Common Stock | -135.25M | -9.07M | -24.00M | -1.19M | -7.23M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -13.00K | -3.74M | -825.00K | -- |
| Cash from Financing | -10.13M | -9.12M | -27.83M | 48.00K | -7.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.52M | 26.25M | -28.90M | 18.66M | -31.52M |